CNBCLean R·
French biotech stock soars 34% after new data on experimental medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
Read at CNBC →
New York TimesLean L
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.
<iframe src="https://statesidedaily.com/embed/cluster/bd95f7e1b67f73f6262db5d140aac590f27f9ab0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="French biotech stock soars 34% after new data on experimental medicine"></iframe>